Skip to main content
Equibles
SSKN logo

SSKN · STRATA Skin Sciences, Inc.

Track SSKN — free

Use SSKN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about SSKN

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.00 +0.00 (+0.00%) At close · Aug 14
Going-concern doubt — flagged Mar 26, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Our history of operating losses and current default on our long-term debt raise substantial doubt regarding our ability to continue as a going concern.”
View the 10-K filed Mar 26, 2026
Market Cap
$588
Shares
5.89M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.00 Open$0.00 Day$0.00–0.00 52W close$0.00–2.83 Avg vol 30d10K Short int59K · 1.0% float · 2.6d Short vol65% Last earningsNov 13, 2025 DataJun 2024–Aug 2026 Filing10-K · Mar 26

Raw chart and full-history price indicators begin at the captured split on Jun 7, 2024; bars on opposite sides are not compared.

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-K
filed Mar 26, 2026

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Very Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 14.3 · calm Equity put/call 0.52
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −100%
below
Price vs 50-day avg −100%
below
RSI (14) 29
oversold
MACD trend Positive
52-week position 0%
near low
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Very Weak
1-month return −100%
trailing
6-month return −100%
trailing
YTD return −100%
this year
Relative strength −114%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Distributing
-18% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
1.00% of float · ▬ 0.0% MoM · 2.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
14 holders — near 3-yr low, contrarian setup
Squeeze score 43
elevated · 0–100
Fundamentals
Strong
Gross margin 6421%
EPS growth +49%
Y/Y
Free cash flow $-4.3M
Balance sheet $7.4M
net debt
Quant / Vol
risk profile
Very High
Volatility 1181%
annualized · 1-yr
Max drawdown −100%
past year
ATR 11400.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
3 · 2 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−100% Bearish
Price vs 50-day avg
−100% Bearish
RSI (14)
29 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Distributing
-18% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
1.00% of float · ▬ 0.0% MoM · 2.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
14 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0 Now $0 · 0% Range high $3
vs 200-day avg -100% vs 50-day avg -100%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SSKN
STRATA Skin Sciences, Inc.
this stock
$588 -100.0% -8.5% — 1.0%
ABT
Abbott Laboratories
 $193.78B -11.2% +5.7% 31.2 1.3%
SYK
Stryker Corp
 $130.11B -3.5% +11.2% 35.2 2.2%
MDT
Medtronic plc
 $116.83B -5.0% +8.4% 24.5 1.4%
BSX
Boston Scientific Corp
 $75.11B -45.6% +12.5% 21.0 1.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
14
% held
18.5%
Net QoQ
-62.2K sh
Top holder
22NW, LP
Held Float
View
Short & Settlement
Short Interest
Shares short
59.0K
Days to cover
2.6d
Change
0 sh
View
Short Volume
Short vol %
65%
As of
Jul 24, 2026
Short Total
View
Fails to Deliver
FTD shares
5
Value
$1
As of
Jun 30, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Jul 6, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$30.7M
Net income (FY)
$-6.3M
EPS diluted
$-1.35
View
Filings
SEC Filings
Latest
10-K
Filed
Mar 26, 2026
This year
2
View
Exempt Offerings
Offering
$480.2K
Filed
Jan 20, 2022
View
Earnings & Events
Earnings Calls
Last call
Nov 13, 2025
View

Performance

Raw-price comparisons begin at the captured split on Jun 7, 2024; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
SSKN -98.2% -99.9% -100.0% -98.2% -100.0%
SPY +0.4% +4.5% +13.8% +3.9% +13.9%
vs SPY -98.6% -104.4% -113.8% -102.1% -113.8%
Key facts CIK 1051514 CUSIP 86272A305 Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)